1Clark SF. Iron deficiency anemia: diagnosis and management[ J]. Curr Opin Gastroenterol. 2009 ;25 (2) : 122-8.
2Kalantar-Zadeh K, Streja E, Miller JE, et al. Intravenous iron versus erythropoiesis-stimulating agents:friends or foes in treating chronic kidney disease anemia[ J ]. Adv Chronic Kidney Dis, 2009,16 ( 2 ) : 143- 151.
3Anraku M, Kitamura K, Shintomo R, et al. Effect of intravenous iron administration frequency on AOPP and, inflammatory biomarkers in chronic hemodialysis patients : a pilot study [ J ]. Clin Biochem, 2008, 41 ( 14-15 ) : 1168-1174.
4Anand IS. Anemia and chronic heart failure implications and treatment options [ J ]. J Am Coll Cardiol,2008,52 (7) :501-511.
5Gameata L. Intravenous iron, inflammation, and oxidative stress : is iron a friend or an enemy of uremic patients [ J ]. J Ren Nutr,2008,18 ( 1 ) : 40 -45.
6Bayes B, Pastor MC, Bonal J, et al. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis-role of seniority and intravenous ferrotherapy : analysis at 4 years of follow-up [ J ]. Nephrol Dial Transplant ,2006,21 (4) :984-990.
9National Kidney Fundation:K/DOQI Clinical Practice Guidelines:Anemia of chronic Kidney Disease:Update 2000[J].Am J Kidney Dis 37:S182-S238,2001(suppl 1)
10Tovbin D,Mazor D,Vorobiov M,et al.Induction of protein oxidation by intravenous iron in hemodialysis patients:Role of inflammation[J].Am J Kidney Dis,2002,40:1005-1012.
